深度学习增强了对外来病原体中HLA类I呈现的CD8+ T细胞表位的预测
Jeremy Wohlwend1,2, Anusha Nathan3,4, Nitan Shalon1,2
1Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA USA.
Nature machine intelligence
|February 26, 2025
概括
一个新的深度学习模型MUNIS准确地预测了由人类白细胞抗原I类 (HLA-I) 分子呈现的CD8+T细胞表位. 这一进步加速了基于T细胞的疫苗的开发,改善了表位标识,减少了实验需求.
科学领域:
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
- 疫苗开发 疫苗开发
背景情况:
- 准确预测CD8+ T细胞表位是开发有效的基于T细胞的疫苗的关键.
- 目前用于人类白细胞抗原I类 (HLA-I) 连接体和表位体的in silico预测模型在可靠性和性能方面存在局限性.
- 机器学习方法显示出解决复杂的生物预测任务的前景.
研究的目的:
- 开发一种先进的深度学习模型,以精确地在体中确定由HLA-I等位基呈现的CD8+T细胞表位.
- 与现有的计算方法相比,改进呈现和免疫主导等级的预测.
- 通过实验测试来验证模型的性能,用于T细胞表位标识.
主要方法:
- 策划了651,237个独特的人类白细胞抗原I类 (HLA-I) 配体的大量数据集.
- 开发了MUNIS,这是一种用于预测HLA-I呈现的新型深度学习模型.
- 将MUNIS应用于爱斯坦-巴尔病毒蛋白质以进行表位体识别.
- 使用体外HLA-I稳定性和T细胞免疫性试验,实验验证的预测表位.
主要成果:
- 与现有模型相比,MUNIS在预测呈现和CD8+ T细胞表皮质免疫主导等级方面表现得更好.
- 该模型成功地从爱斯坦-巴尔病毒蛋白中识别了已知的和新的HLA-I表位.
- 实验验证证证实了已确定表位的稳定性和免疫性.
- 在预测免疫性方面,MUNIS的性能与实验稳定性测试相美.
结论:
- 深度学习,以MUNIS为例,可以显著提高CD8+T细胞表位标识的准确性和效率.
- MUNIS有可能减少实验负担并加速开发基于T细胞的疫苗.
- 该模型为发现和验证用于疫苗设计和免疫治疗的T细胞表位的强大工具.
相关概念视频
T Cell Activation and Clonal Selection
625
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
625
Antigens Involved in Adaptive Immunity
436
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
436


